⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALLO News
Allogene Therapeutics, Inc. Common Stock
Allogene Therapeutics Reports Third Quarter 2025 Financial Results and Business Update
globenewswire.com
ALLO
Allogene Therapeutics Announces ALPHA3 Trial-in-Progress Poster Presentation at ASH Annual Meeting
globenewswire.com
ALLO
Allogene Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update
globenewswire.com
ALLO